caffeine citrate NDC 25021-602

NDC codes

FDA NDC Directory

Product NDC (as listed)25021-602Labeler and product segments. Claims need a package NDC.

Product NDC at billing width25021-0602Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
25021-602-03	25021060203	10 VIAL in 1 CARTON (25021-602-03) / 3 mL in 1 VIALMarketed from Sep 15, 2012

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): caffeine citrate
Generic name (nonproprietary): caffeine citrate
Active ingredients: Caffeine citrate — 20 mg/mL
Dosage form: Solution
Route: Oral
Labeler: Sagent Pharmaceuticals
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091102
Marketing start: Sep 15, 2012
Listing expires: Dec 31, 2027
Other FDA classes: Central Nervous System Stimulation (Physiologic effect)Xanthines (Chemical structure)
Identifiers: Product ID 25021-602_73d572f6-4f18-4198-9ffa-ec68ce101711SPL ID 73d572f6-4f18-4198-9ffa-ec68ce101711SPL set ID 5f38c395-0093-4afd-89ec-f96e5dc0934aRxCUI 849928, 849931UNII U26EO4675Q
Pharmacologic class: Central Nervous System Stimulant; Methylxanthine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N425021060203 followed by a unit qualifier and the quantity

Package 25021-0602-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 29, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE Caffeine citrate is indicated for the treatment of apnea of prematurity.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)